Jacqueline T. Brown

938 total citations
72 papers, 544 citations indexed

About

Jacqueline T. Brown is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Jacqueline T. Brown has authored 72 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 31 papers in Surgery and 31 papers in Oncology. Recurrent topics in Jacqueline T. Brown's work include Renal cell carcinoma treatment (22 papers), Bladder and Urothelial Cancer Treatments (21 papers) and Cancer Immunotherapy and Biomarkers (21 papers). Jacqueline T. Brown is often cited by papers focused on Renal cell carcinoma treatment (22 papers), Bladder and Urothelial Cancer Treatments (21 papers) and Cancer Immunotherapy and Biomarkers (21 papers). Jacqueline T. Brown collaborates with scholars based in United States, United Kingdom and United Arab Emirates. Jacqueline T. Brown's co-authors include Barry V. Charlwood, Mehmet Asım Bilen, Bradley Curtis Carthon, Ömer Küçük, Bassel Nazha, Paul K. Hegarty, D. V. Banthorpe, G. S. Morris, Sarah Caulfield and Viraj A. Master and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jacqueline T. Brown

64 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacqueline T. Brown United States	14	180	163	133	128	85	72	544
Yoshiaki Okuno Japan	20	248 1.4×	231 1.4×	78 0.6×	57 0.4×	35 0.4×	41	796
Ana Tovar Brazil	16	30 0.2×	142 0.9×	70 0.5×	128 1.0×	36 0.4×	33	576
Takae Kataoka Japan	9	150 0.8×	109 0.7×	67 0.5×	212 1.7×	93 1.1×	27	516
Austin R. Dosch United States	13	294 1.6×	188 1.2×	107 0.8×	126 1.0×	38 0.4×	30	659
Paolo Grassi Italy	16	193 1.1×	288 1.8×	303 2.3×	93 0.7×	94 1.1×	75	704
Yiqing Xu United States	15	393 2.2×	393 2.4×	176 1.3×	99 0.8×	25 0.3×	48	891
Jitendra Patel United Kingdom	11	77 0.4×	145 0.9×	149 1.1×	149 1.2×	12 0.1×	28	555
Yun Cai China	13	200 1.1×	292 1.8×	50 0.4×	34 0.3×	62 0.7×	32	634
Masatoshi Kochi Japan	8	100 0.6×	205 1.3×	79 0.6×	60 0.5×	10 0.1×	26	355
H. M. C. Shantha Kumara United States	15	186 1.0×	243 1.5×	58 0.4×	99 0.8×	53 0.6×	37	518

Countries citing papers authored by Jacqueline T. Brown

Since Specialization

Citations

This map shows the geographic impact of Jacqueline T. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline T. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline T. Brown more than expected).

Fields of papers citing papers by Jacqueline T. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline T. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline T. Brown. The network helps show where Jacqueline T. Brown may publish in the future.

Co-authorship network of co-authors of Jacqueline T. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline T. Brown. A scholar is included among the top collaborators of Jacqueline T. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline T. Brown. Jacqueline T. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yuan, Bassel Nazha, Mehmet Asım Bilen, et al.. (2025). Real-world analysis of efficacy and safety of biweekly gemcitabine and docetaxel (GEMDOC) in heavily pretreated metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 43(16_suppl).

Liu, Yuan, Bassel Nazha, Jacqueline T. Brown, et al.. (2025). Phase 2 study of perioperative lenvatinib (L) with pembrolizumab (P) in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 555–555.

Jain, Rohit, Umang Swami, Georges Gebrael, et al.. (2025). Cabozantinib plus Pembrolizumab as First-line Therapy for Cisplatin-ineligible Advanced Urothelial Carcinoma: The PemCab Trial. European Urology Oncology. 8(4). 952–960.

Liu, Yuan, Dylan J. Martini, Wayne Harris, et al.. (2025). Non-clear cell renal cell carcinoma in the immune checkpoint era: A retrospective study on survival and treatment approaches.. Journal of Clinical Oncology. 43(5_suppl). 512–512. 1 indexed citations

Martini, Dylan J., Kathryn L. Pellegrini, Elizabeth Beagle, et al.. (2024). PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation. Cancer. 130(21). 3658–3670. 4 indexed citations

Nazha, Bassel, Jacqueline T. Brown, Yu Liu, et al.. (2024). Enfortumab vedotin plus pembrolizumab in the treatment of locally advanced or metastatic bladder cancer of variant histology: A phase II study.. Journal of Clinical Oncology. 42(16_suppl). TPS4615–TPS4615. 1 indexed citations

Jain, Rohit, Umang Swami, Mehmet Asım Bilen, et al.. (2024). Cabozantinib plus pembrolizumab as first-line therapy for cisplatin-ineligible advanced urothelial carcinoma (PemCab).. Journal of Clinical Oncology. 42(4_suppl). 539–539. 1 indexed citations

Martini, Dylan J., Samuel Bidot, Bassel Nazha, et al.. (2024). Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes. American Journal of Clinical Pathology. 163(4). 618–628. 2 indexed citations

Nazha, Bassel, Sharon Wu, Jacqueline T. Brown, et al.. (2023). Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers. Cancer. 129(24). 3884–3893. 21 indexed citations

10.

Sanda, Gregory E., Julie M. Shabto, Subir Goyal, et al.. (2023). Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors. The Oncologist. 28(12). 1072–1078. 7 indexed citations

11.

Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2022). Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience. SHILAP Revista de lepidopterología. 5(3). 52–57. 1 indexed citations

12.

Smith, Katherine E., Jacqueline T. Brown, Sarah Caulfield, et al.. (2022). Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer. Urologic Oncology Seminars and Original Investigations. 40(6). 271.e9–271.e18. 13 indexed citations

13.

Brown, Jacqueline T., et al.. (2021). Characterization of nuclear pore complex targeting domains in Pom152 in Saccharomyces cerevisiae. Biology Open. 10(10). 1 indexed citations

14.

Ravindranathan, Deepak, Yuan Liu, Dylan J. Martini, et al.. (2021). Clinical outcomes in metastatic renal cell carcinoma (mRCC) treated with combination of nivolumab and cabozantinib (nivo-cabo) in the salvage setting.. Journal of Clinical Oncology. 39(15_suppl). e16570–e16570. 1 indexed citations

15.

Shabto, Julie M., Dylan J. Martini, Yuan Liu, et al.. (2020). Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer Medicine. 9(8). 2752–2760. 8 indexed citations

16.

Reed, Daniel, Bethany J. Horton, Margaret E. Moore, et al.. (2019). Immune-related adverse events in advanced NSCLC treated with immunotherapy alone or concurrent chemotherapy and immunotherapy.. Journal of Clinical Oncology. 37(8_suppl). 83–83. 2 indexed citations

17.

Brown, Jacqueline T., et al.. (2016). Patient Engagement for Youth in Multiple Facets of Healthcare in Rhode Island.. PubMed. 99(8). 19–21. 5 indexed citations

18.

Kunk, Paul R., Jacqueline T. Brown, Melissa McShane, Surabhi Palkimas, & B. Gail Macik. (2016). Direct oral anticoagulants in hypercoagulable states. Journal of Thrombosis and Thrombolysis. 43(1). 79–85. 28 indexed citations

19.

Brown, Jacqueline T.. (2003). The Initiation and Maintenance of Callus Cultures. Humana Press eBooks. 6. 57–64. 10 indexed citations

20.

Brown, Jacqueline T. & Barry V. Charlwood. (2003). Organogenesis in Callus Culture. Humana Press eBooks. 6. 65–70. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact